tirzepatide and psoriatic arthritis π¨ First-of-its-kind Phase 3b data: treating obesity improves outcomes Today, Eli Lilly Company announced positive topline results from TOGETHER-PsA, the first controlled trial evaluating an incretin therapy used alongside Ixekizumab With Tirzepatide Achieved Greater
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 7 - Oct 12




























